SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

多発性硬化症（MS）治療機器市場 : 2032年までの予測

Multiple Sclerosis Treatment Devices Market Research Report

Multiple Sclerosis Treatment Devices Market Research Report by Type [Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Relapsing-remitting Multiple Sclerosis (RRMS), Clinically Isolated Syndrome (CIS)], by Treatment Devices [Electrical Stimulation Devices (Functional Electrical Stimulation (FES), Transcutaneous Electrical Nerve Stimulation (TENS)), Neurostimulation Devices (Spinal Cord Stimulation (SCS), Deep Brain Stimulation (DBS))], by End User (Hospitals & Clinics, Ambulatory Surgical Centers), and by Region (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Forecast till 2032

商品番号 : SMB-84437

出版社Market Research Future
出版年月2025年7月
ページ数165
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

多発性硬化症（MS）治療機器市場 : タイプ別（一次性進行性多発性硬化症（PPMS）、二次性進行性多発性硬化症（SPMS）、再発寛解型多発性硬化症（RRMS）、臨床的に孤立した症候群（CIS）、治療機器別（電気刺激装置（機能的電気刺激（FES）、経皮的電気神経刺激（TENS）、神経刺激装置（脊髄刺激（SCS）、脳深部刺激（DBS）））、エンドユーザー別（病院・クリニック、外来手術センター）、地域別（北米、ヨーロッパ、アジア太平洋、南米、中東、アフリカ）2032年までの予測

世界の多発性硬化症（MS）治療機器市場は、2023年に8億1,358万米ドルと評価され、2032年には12億6,387万米ドルに達すると予測されています。多発性硬化症治療機器は、MS患者の症状管理を支援することを目的とした医療機器です。多発性硬化症は、中枢神経系の破壊につながる慢性の自己免疫疾患です。このような機器には、電気刺激システム、ウェアラブルリハビリテーション補助具、移動支援機器などがあります。これらの機器の目的は、使用者の動きを楽にし、痛みを和らげ、患者の生活の質を向上させることです。

Market Overview

The Global Multiple Sclerosis Treatment Devices market was valued at USD 813.58 million in 2023 and is projected to reach USD 1,263.87 million by 2032. Multiple Sclerosis treatment devices are the medical tools that are specifically targeted to support MS patients in managing their symptoms. Multiple sclerosis is an autoimmune disease that is chronic which leads to the destruction of the central nervous system. Such devices are electrical stimulation systems, wearable rehabilitation aids, and mobility-support equipment. The purpose of such devices is to make moving easier for the user, to relieve pain, and to improve the quality of life of the patient.

The global Multiple Sclerosis (MS) Treatment Devices market is growing strongly as a result of the global increase in MS cases. According to the Atlas of MS 2023, nearly 2.9 million people with this disease reside in the world, which is an increase from 2.3 million in 2013. High prevalence rates in North America and Europe, particularly in countries like Canada, Norway, and the UK, are boosting demand for advanced therapeutic solutions.

The market is riding on the back of rapid developments in neurostimulation devices that include transcutaneous electrical nerve stimulation (TENS), spinal cord stimulation (SCS), and functional electrical stimulation (FES) systems, as well as wearable rehabilitation technologies. These solutions provide support in the control of deambulatory issues, decrease spasticity, and relieve symptoms of chronic pain while helping patients to be more independent. The creation of such AI-connected, cloud-connected devices that are monitoring continuously and adjusting treatment according to a patient’s needs is one of the examples of the technological advances in neurostimulation devices.

Nevertheless, a lack of knowledge, insufficient health care structures, as well as high prices of the devices are the main problems in the less developed areas, resulting in the number of undiagnosed cases and low market penetration. As a result of collaborative efforts between healthcare providers and technology firms, this can be seen in several examples, such as AI-powered neuromodulation platforms and sensor-equipped wearables that automatically adjust to the user’s motion, among others. Such partnerships are predicted to improve treatment accessibility, efficiency, and personalization, thus enabling the market to grow steadily over the next few years.

Market Segmentations

In terms of the treatment devices, the global market is segmented into electrical stimulation devices (ESD) and neurostimulation devices. Functional electrical stimulation and transcutaneous electrical nerve stimulation are further segments of the ESD. Spinal cord stimulation and deep brain stimulation are parts of neurostimulation devices.

The global multiple sclerosis treatment devices market is classified based on the type, comprising primary progressive multiple sclerosis, secondary progressive multiple sclerosis, relapsing-remitting multiple sclerosis, and clinically isolated syndrome.

Depending on the end users, the global multiple sclerosis treatment devices market is divided into hospitals & clinics, and ambulatory surgical centers.

Regional Insights

The North American leather market benefits from a top-notch presence of the automotive and fashion industries, which are premium. The U.S. remains a leading consumer, propelled by luxury upholstery demand and footwear production, while Canada contributes with specialty leather goods. Domestic tanners are transforming towards green processing so as to be in line with the new regulations. Asian imports fill up the gap for high-grade raw hides, and at the same time, export opportunities for finished leather products remain stable.

Europe has indeed a centuries-old heritage in leather craftsmanship, with Italy, France, and Spain as the main contributors. Luxury fashion houses, premium car interiors, and designer accessories are the main drivers of the region’s market. Strict environmental regulations force manufacturers to produce using chrome-free tanning and eco-certified processes. EU trade agreements facilitate the movement of raw material into the region as well as the transport of finished goods to other markets, hence better global competitiveness.

Asia-Pacific is indisputably the world leader in leather production, and China and India are undeniably the top tanning and manufacturing capacities. The combination of low production costs and plentiful raw materials is what drives exports of leather goods to Europe and North America. Domestic demand in emerging economies is on the rise, with increased incomes and urban fashion trends as the main factors. Sustainability ideas are becoming more and more well-known, especially in Japan and South Korea.

Brazil is the largest leather exporter in the South American region, and it is mainly focused on bovine hides. Argentina mostly supplies the premium leather industry with products that play a key role. Environmental issues and deforestation debates are some of the problems that the industry has to deal with, even though strong livestock production remains as a backbone of the industry. Demand from Asian buyers keeps the export market solid.

The Middle Eastern economy is flourishing with luxurious leather that has been imported from other countries, which are mainly for luxury products, and is driven by the consumers’ high purchasing power. Turkey and Egypt are the main production hubs for the region. Africa is the place where Ethiopia’s leather industry is growing with the establishment of industrial parks that are backed up by the government. But, still,

Major Players

Major competitors in the global multiple sclerosis treatment devices market are Medtronic, Abbott, Boston Scientific Corporation, Biotronik, Saluda Medical Pty Ltd., Enovis, Bayer, Koninklijke Philips N.V., BTL, and Axonics Inc.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY …… 20

2 MARKET INTRODUCTION … 22

2.1 DEFINITION …….. 22

2.2 SCOPE OF THE STUDY ……….. 22

2.3 RESEARCH OBJECTIVE ………. 22

2.4 MARKET STRUCTURE ……….. 23

3 RESEARCH METHODOLOGY ……………… 24

3.1 OVERVIEW ……… 24

3.2 DATA FLOW ……. 26

3.2.1 DATA MINING PROCESS … 26

3.3 PURCHASED DATABASE: …… 27

3.4 SECONDARY SOURCES: …….. 28

3.4.1 SECONDARY RESEARCH DATA FLOW: …. 29

3.5 PRIMARY RESEARCH: ……….. 30

3.5.1 PRIMARY RESEARCH DATA FLOW: …….. 31

3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED ………. 32

3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE ………….. 32

3.6 APPROACHES FOR MARKET SIZE ESTIMATION: …… 33

3.6.1 REVENUE ANALYSIS APPROACH ………… 33

3.7 DATA FORECASTING…………. 34

3.7.1 DATA FORECASTING TYPE ………………… 34

3.8 DATA MODELING ……………… 35

3.8.1 MICROECONOMIC FACTOR ANALYSIS: … 35

3.8.2 DATA MODELING: …………. 36

3.9 TEAMS AND ANALYST CONTRIBUTION ………………… 38

3.10 INTRODUCTION ………………… 40

3.11 DRIVERS ………….. 40

3.11.1 INCREASING PREVALENCE OF MULTIPLE SCLEROSIS (MS) …………… 40

3.11.2 ADVANCEMENTS IN NEUROSTIMULATION AND WEARABLE DEVICES ………………… 41

3.12 RESTRAINTS ……. 42

3.12.1 LIMITED AWARENESS AND ACCESSIBILITY IN DEVELOPING REGIONS ……………….. 42

3.13 OPPORTUNITY .. 44

3.13.1 RISING COLLABORATIONS BETWEEN HEALTHCARE PROVIDERS AND TECHNOLOGY FIRMS ……… 44

4 MARKET FACTOR ANALYSIS ……………… 45

4.1 PORTER’S FIVE FORCES MODEL ………….. 45

4.1.1 THREAT OF NEW ENTRANTS ……………… 46

4.1.2 BARGAINING POWER OF SUPPLIERS …… 46

4.1.3 THREAT OF SUBSTITUTES ………………… 46

4.1.4 BARGAINING POWER OF BUYERS ……….. 46

4.1.5 INTENSITY OF RIVALRY …. 46

4.2 IMPACT OF COVID-19 ON THE GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET ….. 47

5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE …. 49

5.1 OVERVIEW ……… 49

5.2 PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS) ………….. 51

5.3 SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS) ……… 51

5.4 RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) ………….. 52

5.5 CLINICALLY ISOLATED SYNDROME (CIS) ……………… 52

6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES…. 53

6.1 INTRODUCTION ………………… 53

6.2 ELECTRICAL STIMULATION DEVICES …. 55

6.2.1 FUNCTIONAL ELECTRICAL STIMULATION (FES) ……….. 55

6.2.2 TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS) ……… 56

6.3 NEUROSTIMULATION DEVICES …………… 56

6.3.1 SPINAL CORD STIMULATION (SCS) …….. 57

6.3.2 DEEP BRAIN STIMULATION (DBS) ………. 58

7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER ……………. 59

7.1 OVERVIEW ……… 59

7.2 HOSPITALS & CLINICS ………. 60

7.3 AMBULATORY SURGICAL CENTERS ……. 61

8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET BY REGION . 62

8.1 OVERVIEW ……… 62

8.2 NORTH AMERICA ……………… 64

8.2.1 US…………… 67

8.2.2 CANADA ….. 69

8.3 EUROPE …………… 71

8.3.1 GERMANY … 75

8.3.2 FRANCE …… 77

8.3.3 UK ………….. 78

8.3.4 SPAIN ……… 80

8.3.5 ITALY ………. 81

8.3.6 RUSSIA ……. 83

8.3.7 REST OF EUROPE ………….. 85

8.4 ASIA PACIFIC ….. 87

8.4.1 CHINA ……… 91

8.4.2 INDIA ………. 92

8.4.3 JAPAN …….. 94

8.4.4 SOUTH KOREA ……………… 96

8.4.5 MALAYSIA .. 97

8.4.6 THAILAND … 99

8.4.7 INDONESIA .. 101

8.4.8 REST OF ASIA PACIFIC…… 103

8.5 SOUTH AMERICA ………………. 105

8.5.1 BRAZIL …….. 109

8.5.2 MEXICO …… 111

8.5.3 ARGENTINA ………………… 113

8.5.4 REST OF SOUTH AMERICA ………………… 115

8.6 MIDDLE EAST AND AFRICA . 117

8.6.1 GCC COUNTRIES…………… 121

8.6.2 SOUTH AFRICA …………….. 123

8.6.3 REST OF MEA ………………. 125

9 COMPETITIVE LANDSCAPE ……………….. 128

9.1 INTRODUCTION ………………… 128

9.2 MARKET SHARE ANALYSIS, 2023 …………. 128

9.3 COMPETITOR DASHBOARD ………………… 129

9.4 PUBLIC PLAYERS STOCK SUMMARY …… 130

9.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANCIAL ……………. 130

9.1 KEY DEVELOPMENTS & GROWTH STRATEGIES ……. 131

9.1.1 PRODUCT LAUNCH ……….. 131

9.1.2 PRODUCT APPROVAL ……. 131

10 COMPANY PROFILES ……… 132

10.1 ENOVIS ……………. 132

10.1.1 COMPANY OVERVIEW ……. 132

10.1.2 FINANCIAL OVERVIEW …… 133

10.1.3 PRODUCTS OFFERED …….. 133

10.1.4 KEY DEVELOPMENTS …….. 133

10.1.5 SWOT ANALYSIS ………….. 134

10.1.6 KEY STRATEGIES ………….. 134

10.2 AXONICS, INC. … 135

10.2.1 COMPANY OVERVIEW ……. 135

10.2.2 FINANCIAL OVERVIEW …… 136

10.2.3 PRODUCTS OFFERED …….. 137

10.2.4 KEY DEVELOPMENTS …….. 137

10.2.5 KEY STRATEGIES ………….. 137

10.3 KONINKLIJKE PHILIPS N.V. .. 138

10.3.1 COMPANY OVERVIEW ……. 138

10.3.2 FINANCIAL OVERVIEW …… 139

10.3.3 PRODUCTS OFFERED …….. 139

10.3.4 KEY DEVELOPMENTS …….. 140

10.3.5 SWOT ANALYSIS ………….. 140

10.3.6 KEY STRATEGIES ………….. 141

10.4 BTL .. 142

10.4.1 COMPANY OVERVIEW ……. 142

10.4.2 FINANCIAL OVERVIEW …… 142

10.4.3 PRODUCTS OFFERED …….. 142

10.4.4 KEY DEVELOPMENTS …….. 143

10.4.5 KEY STRATEGIES ………….. 143

10.5 BAYER AG ……….. 144

10.5.1 COMPANY OVERVIEW ……. 144

10.5.2 FINANCIAL OVERVIEW …… 145

10.5.3 PRODUCTS OFFERED …….. 145

10.5.4 KEY DEVELOPMENTS …….. 145

10.5.5 KEY STRATEGY …………….. 146

10.6 MEDTRONIC ……. 147

10.6.1 COMPANY OVERVIEW ……. 147

10.6.2 FINANCIAL OVERVIEW …… 148

10.6.3 PRODUCTS OFFERED …….. 149

10.6.4 KEY DEVELOPMENTS …….. 149

10.6.5 SWOT ANALYSIS ………….. 150

10.6.6 KEY STRATEGIES ………….. 150

10.7 ABBOTT …………… 151

10.7.1 COMPANY OVERVIEW ……. 151

10.7.2 FINANCIAL OVERVIEW …… 152

10.7.3 PRODUCTS OFFERED …….. 152

10.7.4 KEY DEVELOPMENTS …….. 153

10.7.5 SWOT ANALYSIS ………….. 153

10.7.6 KEY STRATEGIES ………….. 154

10.8 BOSTON SCIENTIFIC CORPORATION ….. 155

10.8.1 COMPANY OVERVIEW ……. 155

10.8.2 FINANCIAL OVERVIEW …… 156

10.8.3 PRODUCTS OFFERED …….. 157

10.8.4 KEY DEVELOPMENTS …….. 157

10.8.5 KEY STRATEGIES ………….. 157

10.9 BIOTRONIK……… 158

10.9.1 COMPANY OVERVIEW ……. 158

10.9.2 FINANCIAL OVERVIEW …… 158

10.9.3 PRODUCTS OFFERED …….. 159

10.9.4 KEY DEVELOPMENTS …….. 159

10.9.5 KEY STRATEGIES ………….. 159

10.10 SALUDA MEDICAL PTY LTD. ……………….. 160

10.10.1 COMPANY OVERVIEW ……. 160

10.10.2 FINANCIAL OVERVIEW …… 160

10.10.3 PRODUCTS OFFERED …….. 161

10.10.4 KEY DEVELOPMENTS …….. 161

10.10.5 KEY STRATEGIES ………….. 161

11 DATA CITATIONS ……………. 162

11.1 DATA CITATIONS ………………. 163

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT 36

TABLE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION) 50

TABLE 3 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR PRIMARY PROGRESSIVE MULTIPLE SCLEROSIS (PPMS), BY

REGION, 2019-2032 (USD MILLION) 51

TABLE 4 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY

REGION, 2019-2032 (USD MILLION) 51

TABLE 5 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS (SPMS), BY

REGION, 2019-2032 (USD MILLION) 52

TABLE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR CLINICALLY ISOLATED SYNDROME (CIS), BY REGION, 2019-2032

(USD MILLION) 52

TABLE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2019-2032 (USD MILLION) 54

TABLE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY REGION, 2019-2032

(USD MILLION) 55

TABLE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION) 55

TABLE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR FUNCTIONAL ELECTRICAL STIMULATION (FES), BY REGION,2019-2032 (USD MILLION) REGION 55

TABLE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR TRANSCUTANEOUS ELECTRICAL NERVE STIMULATION (TENS),

BY REGION, 2019-2032 (USD MILLION) 56

TABLE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY REGION, 2019-2032 (USD MILLION) 56

REGION 56

TABLE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD

MILLION) 57

TABLE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR SPINAL CORD STIMULATION (SCS), BY REGION, 2019-2032 (USD

MILLION) 57

REGION 57

TABLE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR DEEP BRAIN STIMULATION (DBS), BY REGION, 2019-2032 (USD

MILLION) 58

REGION 58

TABLE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION) 60

TABLE 17 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR HOSPITALS & CLINICS, BY REGION, 2019-2032 (USD MILLION)

60

REGION 60

TABLE 18 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2019-2032 (USD

MILLION) 61

REGION 61

TABLE 19 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2019-2032 (USD MILLION) 62

TABLE 20 NORT AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION) 65

TABLE 21 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION) 66

TABLE 22 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION) 66

TABLE 23 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 24 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 25 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 26 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)

TABLE 27 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)

TABLE 28 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 29 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 30 US MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 31 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)

TABLE 32 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)

TABLE 33 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 34 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 35 CANADA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 36 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2019-2032 (USD MILLION)

TABLE 37 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)

TABLE 38 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)

TABLE 39 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 40 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 41 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 42 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)

TABLE 43 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)

TABLE 44 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 45 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 46 GERMANY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 47 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)

TABLE 48 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)

TABLE 49 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 50 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 51 FRANCE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 52 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION)

TABLE 53 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION)

TABLE 54 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 55 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

TABLE 56 UK MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION)

TABLE 57 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION) 80

TABLE 58 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION) 80

TABLE 59 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD

MILLION) 80

TABLE 60 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD

MILLION) 81

TABLE 61 SPAIN MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION) 81

TABLE 62 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION) 81

TABLE 63 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION) 82

TABLE 64 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD

MILLION) 82

TABLE 65 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD MILLION)

82

TABLE 66 ITALY MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION) 83

TABLE 67 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION) 83

TABLE 68 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION) 83

TABLE 69 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019-2032 (USD

MILLION) 84

TABLE 70 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032 (USD

MILLION) 84

TABLE 71 RUSSIA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION) 84

TABLE 72 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2019-2032 (USD MILLION) 85

TABLE 73 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT, 2019-2032 (USD MILLION) 85

TABLE 74 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019

2032 (USD MILLION) 85

TABLE 75 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019-2032

(USD MILLION) 86

TABLE 76 REST OF EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2019-2032 (USD MILLION) 86

TABLE 77 ASIA PACIFIC MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019–2032 (USD MILLION) 88

TABLE 78 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION) 89

TABLE 79 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD

MILLION) 89

TABLE 80 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION) 90

TABLE 81 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION) 90

TABLE 82 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 90

TABLE 83 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION) 91

TABLE 84 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

91

TABLE 85 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION) 91

TABLE 86 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2032

(USD MILLION) 92

TABLE 87 CHINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 92

TABLE 88 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION) 92

TABLE 89 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION) 93

TABLE 90 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019

2032 (USD MILLION) 93

TABLE 91 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 92 INDIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 93 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 94 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 95 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 96 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019 – 2032 (USD MILLION)

TABLE 97 JAPAN: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 98             SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 99 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 100 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION)

TABLE 101 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 102 SOUTH KOREA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 97

TABLE 103 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 104 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 105 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 106 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019

2032 (USD MILLION)

TABLE 107 MALAYSIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 108 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 109 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 110 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 111 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019

2032 (USD MILLION)

TABLE 112 THAILAND: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 113 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 114 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 115 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 116 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019

TABLE 117 INDONESIA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 118 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 119 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032

(USD MILLION)

TABLE 120 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION

DEVICES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 121 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION)

TABLE 122 REST OF ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 123 SOUTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY REGION, 2019–2032 (USD MILLION) 106

TABLE 124 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 125 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD

MILLION)

TABLE 126 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION)

TABLE 127 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 128 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 129 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 130 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 131 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 132 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019

2032 (USD MILLION)

TABLE 133 BRAZIL: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 134 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 135 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 136 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 137 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE, 2019

2032 (USD MILLION)

TABLE 138 MEXICO: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 139 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 140 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 141 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 142 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 143 ARGENTINA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION)

TABLE 144 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 145 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032

(USD MILLION)

TABLE 146 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION

DEVICES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 147 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES,

BY TYPE, 2019–2032 (USD MILLION)

TABLE 148 REST OF SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD

MILLION)

TABLE 149 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 150 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 151 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032

(USD MILLION)

TABLE 152 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION

DEVICES, BY TYPE, 2019–2032 (USD MILLION)

TABLE 153 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES,

BY TYPE, 2019–2032 (USD MILLION)

TABLE 154 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD

MILLION)

TABLE 155 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 156 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD

MILLION)

TABLE 157 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION)

TABLE 158 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 159 GCC COUNTRIES: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 122

TABLE 160 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 161 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD MILLION)

TABLE 162 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION)

TABLE 163 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 164 SOUTH AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 124

TABLE 165 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TYPE, 2019–2032 (USD MILLION)

TABLE 166 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY TREATMENT DEVICE, 2019–2032 (USD

MILLION)

TABLE 167 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR ELECTRICAL STIMULATION DEVICES, BY

TYPE, 2019–2032 (USD MILLION)

TABLE 168 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, FOR NEUROSTIMULATION DEVICES, BY TYPE,

2019–2032 (USD MILLION)

TABLE 169 REST OF MEA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, BY END USER, 2019–2032 (USD MILLION) 126

TABLE 170 PRODUCT LAUNCH

TABLE 171 PRODUCT APPROVAL

TABLE 172 ENOVIS: PRODUCTS OFFERED

TABLE 173 AXONICS, INC.: PRODUCTS OFFERED

TABLE 174 KONINKLIJKE PHILIPS N.V.: PRODUCTS OFFERED

TABLE 175 BTL: PRODUCT OFFERED

TABLE 176 BAYER AG: PRODUCTS OFFERED

TABLE 177 MEDTRONIC: PRODUCTS OFFERED

TABLE 178 MEDTRONIC: KEY DEVELOPMENTS

TABLE 179 ABBOTT: PRODUCTS OFFERED

TABLE 180 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED

TABLE 181 ABBOTT: KEY DEVELOPMENTS

TABLE 182 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED

TABLE 183 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS

LIST OF FIGURES

FIGURE 1 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: STRUCTURE 23

FIGURE 2 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)  40

FIGURE 3 DRIVER IMPACT ANALYSIS (2022-2032) 42

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2022-2032) 43

FIGURE 5 PORTER’S FIVE FORCES ANALYSIS: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET 45

FIGURE 6 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TYPE SEGMENT ATTRACTIVENESS, (USD MILLION) 49

FIGURE 7 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TYPE, 2023 & 2032 (USD MILLION) 50

FIGURE 8 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TYPE, 2023 50

FIGURE 9 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; TREATMENT DEVICES SEGMENT ATTRACTIVENESS, (USD MILLION)

53

FIGURE 10 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY TREATMENT DEVICES, 2023 & 2032 (USD MILLION) 54

FIGURE 11 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY TREATMENT DEVICES, 2023 54

FIGURE 12 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET; END USER SEGMENT ATTRACTIVENESS, (USD MILLION) 59

FIGURE 13 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY END USER, 2023 & 2032 (USD MILLION) 59

FIGURE 14 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY END USER, 2023 60

FIGURE 15 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY REGION, 2023 & 2032 (USD MILLION) 62

FIGURE 16 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY REGION, 2023 63

FIGURE 17 NORTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2032 (USD MILLION) 64

FIGURE 18 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) 65

FIGURE 19 NORTH AMERICA MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2023 65

FIGURE 20 EUROPE MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, 2019-2032 (USD MILLION) 71

FIGURE 21 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION) 72

FIGURE 22 EUROPE MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET SHARE (%), BY COUNTRY, 2023 73

FIGURE 23 ASIA PACIFIC MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)

87

FIGURE 24 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD MILLION)

88

FIGURE 25 ASIA PACIFIC: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%) 89

FIGURE 26 SOUTH AMERICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD MILLION)

105

FIGURE 27 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032 (USD

MILLION) 106

FIGURE 28 SOUTH AMERICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%) 107

FIGURE 29 MIDDLE EAST AND AFRICA MARKET ANALYSIS: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET, 2019-2032 (USD

MILLION) 117

FIGURE 30 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 & 2032

(USD MILLION) 118

FIGURE 31 MIDDLE EAST AND AFRICA: MULTIPLE SCLEROSIS TREATMENT DEVICES TREATMENT MARKET SHARE, BY COUNTRY, 2023 (%) 118

FIGURE 32 GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023 128

FIGURE 33 COMPETITOR DASHBOARD: GLOBAL MULTIPLE SCLEROSIS TREATMENT DEVICES MARKET 129

FIGURE 34 ENOVIS: FINANCIAL OVERVIEW SNAPSHOT 133

FIGURE 35 ENOVIS: SWOT ANALYSIS 134

FIGURE 36 AXONICS, INC.: FINANCIAL OVERVIEW SNAPSHOT 136

FIGURE 37 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT 139

FIGURE 38 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 140

FIGURE 39 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT 145

FIGURE 40 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT 148

FIGURE 41 MEDTRONIC: SWOT ANALYSIS 150

FIGURE 42 ABBOTT: FINANCIAL OVERVIEW SNAPSHOT 152

FIGURE 43 ABBOTT: SWOT ANALYSIS 153

FIGURE 44 BOSTON SCIENTIFIC CORPORATION: FINANCIAL OVERVIEW SNAPSHOT 156

医療・医薬の最新記事8件